Brief Information of the Cell Line and Protein
Cell Line ID: CL000108 , CCRF-CEM
 Cell Line Info 
Synonyms
CCRF/CEM
CCRFCEM
CCRF.CEM
CCRF CEM
CCRF
CEM
CEM-CCRF
CEM-CCRF (CAMR)
CCRF/CEM/0
CEM/0
CEM-0
CCRF-CEM/S
GM03671
GM03671C
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0207
Protein ID: PT01546 , ATP-dependent translocase ABCB1
 Protein Info 
Gene Name ABCB1
Organism Homo sapiens, Human
Protein Classification Transporter
Uniprot ID P08183
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000108
 Cell Line Info 
 Protein ID: PT01546
 Protein Info 
 
Compound ID Compound Name Compound Formula
CP0458716
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-15-propan-2-ylidene-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H90N8O10
  1
1
IC50 = 180 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0535520
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 360 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0408797
 Compound Info 
(3S,6S,9S,12R,15R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 390 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0501194
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C57H86N8O10
  1
1
IC50 = 890 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0930903
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-17-(2-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 1090 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0374235
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-24-[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,12,21-tri(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 1100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0883089
 Compound Info 
5,8-Dibenzyl-14-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23,26-triisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 1290 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0397500
 Compound Info 
(3S,6S,9S,12R,18R,21S,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3-propan-2-yl-21,30-dipropyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 1300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860303
 Compound Info 
8-Benzyl-14,26-di-sec-butyl-5-(hydroxy-phenyl-methyl)-20-isobutyl-11,17,23-triisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 1360 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436734
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-3-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 1500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0847531
 Compound Info 
27-Benzyl-30-ethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C70H119N11O12
  1
1
IC50 = 1500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880818
 Compound Info 
21',24'-dibenzyl-3',15'-di(sec-butyl)-9'-isobutyl-6',18'-diisopropyl-3,3,5',11',17',23'-hexamethylspiro[dihydrooxirane-2,12'-perhydropyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine]-1',4',7',10',13',16',19',22',25'-nonaone
   Show/Hide
C60H90N8O11
  1
1
IC50 = 1550 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0377806
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O14
  1
1
IC50 = 1600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430233
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-12-[(2S)-butan-2-yl]-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,15,30,33-tetrakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O14
  1
1
IC50 = 1600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0403760
 Compound Info 
(3S,6S,9S,12R,15S,18S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16-trimethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13,22-dioxa-1,4,7,10,16,19,25-heptazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C59H89N7O12
  1
1
IC50 = 1660 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383533
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 1900 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436807
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,21,24-pentakis(2-methylpropyl)-3-propan-2-yl-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 2000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0466933
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 2000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383528
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,15,30,33-tetrakis(2-methylpropyl)-3,12,27-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 2100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0454670
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,27,33-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 2100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0397299
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-[[4-(cyclohexylmethoxy)phenyl]methyl]-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C61H100N8O12
  1
1
IC50 = 2110 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880790
 Compound Info 
8-Benzyl-14,26-di-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-5-(hydroxy-phenyl-methyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O12
  1
1
IC50 = 2150 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0409417
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 2200 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0465372
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 2270 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0375423
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-27-ethyl-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,33-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 2300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0395441
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-benzyl-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C66H111N11O12
  1
1
IC50 = 2400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0845643
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-20-isobutyl-11,17,23-triisopropyl-6,12,18-trimethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O10
  1
1
IC50 = 2680 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0874522
 Compound Info 
6,9,18,24-Tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-(2-methyl-hept-4-enyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C64H115N11O11
  1
1
IC50 = 2700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0458656
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 2730 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0404597
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28,30-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 3000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0036222
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0405766
 Compound Info 
(3S,6R,9S,12R,15R,18R,24S,27S,30S,33S)-24-ethyl-27-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,9,13,19,22,28-octamethyl-3,12,18,33-tetrakis(2-methylpropyl)-15,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0948457
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-21-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-3-(1-methyl-allyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C63H111N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897117
 Compound Info 
cyclo-[MeBmt-Abu-D-Pro-MeLeu-Val-MeLeu-Ala-D-Ala-MeLeu-MeLeu-MeVal]
   Show/Hide
C62H111N11O12
  1
1
IC50 = 3500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430546
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,25,28-hexamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 4000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0487542
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-hexyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H111N11O11
  1
1
IC50 = 4000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430441
 Compound Info 
(3S,6S,9R,12S,15S,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,19,25,28-hexamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 4300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0932129
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,24-triisobutyl-3,21-diisopropyl-1,4,7,10,12,15,18,19,25,28-decamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 4600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0507105
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28,30-decamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 4700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0409931
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-6-benzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-3,4,10,16-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C53H86N8O11
  1
1
IC50 = 4790 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0463660
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 5100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880813
 Compound Info 
14,26-Di-sec-butyl-8-cyclohexyl-5-hydroxymethyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C53H92N8O12
  1
1
IC50 = 5160 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0907022
 Compound Info 
cyclo-[MeBmt-Abu-L-Pro-MeLeu-Val-MeLeu-Ala-D-Ala-MeLeu-MeLeu-MeVal]
   Show/Hide
C62H111N11O12
  1
1
IC50 = 5200 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436760
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24,33-pentakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H109N11O11
  1
1
IC50 = 5600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0463581
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 5700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0394178
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-[(4-hydroxyphenyl)methyl]-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C54H88N8O12
  1
1
IC50 = 5770 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0878679
 Compound Info 
5-Benzyl-14,26-di-sec-butyl-8-cyclohexyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H96N8O11
  1
1
IC50 = 5880 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430513
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,21,24-pentakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O13
  1
1
IC50 = 6000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0448580
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 6400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0466750
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24,33-pentakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H109N11O11
  1
1
IC50 = 7000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0453115
 Compound Info 
(3S,6S,9S,12S,24S,27R)-12,27-bis[(2S)-butan-2-yl]-3-(2-hydroxypropan-2-yl)-4,10,25-trimethyl-6-(2-methylpropyl)-9,24-di(propan-2-yl)-1-oxa-4,7,10,13,22,25-hexazacycloheptacosane-2,5,8,11,14,23,26-heptone
   Show/Hide
C44H80N6O9
  1
1
IC50 = 7420 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0912339
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18-trimethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 7550 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897852
 Compound Info 
30-Ethyl-6,9,18,24,33-pentaisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C59H107N11O11
  1
1
IC50 = 8000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0404315
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-(cyclohexylmethyl)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 8100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0521923
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-21-[(2S)-butan-2-yl]-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 8400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0373205
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 8800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392628
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 8800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0374685
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21,24-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 11100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0908313
 Compound Info 
30-Ethyl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-(2-methyl-cyclohexyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 13100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430232
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 14100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0506686
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,28-octamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 15000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0470388
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E)-3-methylhept-5-en-2-yl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O11
  1
1
IC50 = 15500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0461449
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-24-[(E,1R,2R)-1,6-dihydroxy-2-methylhex-4-enyl]-3-hydroxy-21-[(1R)-1-hydroxyethyl]-1,6,10,16,19,25,28-heptamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O15
  1
1
IC50 = 15800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0453344
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,3,4,7,10,12,15,19,25,28-decamethyl-6,9,18,24-tetrakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 16100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383534
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-27-[(1R)-1-hydroxyethyl]-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,33-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 17000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0429026
 Compound Info 
(3S,6R,9S,12R,15R,18R,24S,27S,30S,33S)-24-[(1R)-1-hydroxyethyl]-27-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,9,13,19,22,28-octamethyl-3,12,18,33-tetrakis(2-methylpropyl)-15,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 19000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897053
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 23000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0381082
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-24-(2-hydroxy-2-methylpropyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 > 30000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0454580
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-12-(hydroxymethyl)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,15,19,25-heptamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 > 30000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0484579
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-(hydroxymethyl)-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C48H84N8O12
  1
1
IC50 > 31000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392627
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-12-(hydroxymethyl)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 42000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860289
 Compound Info 
15,30-Diethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,19,25,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 50000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0941694
 Compound Info 
33-(1,6-Dihydroxy-2-methyl-hex-4-enyl)-30-ethyl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C62H111N11O13
  1
1
IC50 = 50000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0845551
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O12
  1
1
IC50 > 54000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392579
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,10,12,15,19,25,28-nonamethyl-9,18,21,24-tetrakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C59H105N11O13
  1
1
IC50 = 56000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383986
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436735
 Compound Info 
(3S,6S,9S,12R,15S,18S,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,25,28-heptamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0480618
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0899557
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C61H109N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0916099
 Compound Info 
30-(1-Hydroxy-ethyl)-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O13
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0441218
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27R)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 > 2700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0500984
 Compound Info 
(3S,6S,9S,12R,15S,18S,21R,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 > 2730 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860194
 Compound Info 
14,26-Di-sec-butyl-8-cyclohexyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-5,6,12,18,24-pentamethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C53H92N8O11
  1
1
IC50 > 2910 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0475613
 Compound Info 
3-[(3S,6S,9S,12R,15S,19R,23S,26S,29S)-3,6-dibenzyl-12,26-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,24-tetramethyl-2,5,8,11,14,17,20,22,25,28-decaoxo-9,23-di(propan-2-yl)-13-oxa-1,4,7,10,16,18,21,24,27-nonazabicyclo[27.3.0]dotriacontan-19-yl]propanoic acid
   Show/Hide
C60H89N9O14
  1
1
IC50 > 8960 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS